Tik Bozuklukları ve PANS
Özet
Tik bozuklukları, çocukluk döneminde sıkça rastlanan, istemsiz kasılmalar ve sesler ile kendini gösteren nörogelişimsel durumlardır. Genetik faktörlerin yanı sıra beyindeki kortiko-striatal-talamo-kortikal devrelerdeki işlevsel bozukluklar bu tiklerin temelinde yatmaktadır. Tedavi yaklaşımları arasında alışkanlığı tersine çevirme gibi davranışçı yöntemler, farmakolojik müdahaleler ve nadiren cerrahi girişimler yer almaktadır. PANS ise enfeksiyon sonrası tetiklenen, ani başlangıçlı OKB ve diğer nöropsikiyatrik belirtilerle karakterize olup, tik bozukluklarından farklı bir otoimmün süreç ile ilişkilendirilir.
Tic disorders are common neurodevelopmental conditions in children characterized by involuntary movements and vocalizations. Underlying these symptoms are genetic factors and dysfunctional activity within cortico-striatal-thalamo-cortical neural circuits. Management strategies range from behavioral therapies and pharmacological agents to neurosurgical interventions for severe cases. PANS, by contrast, refers to a distinct, post-infectious autoimmune syndrome involving sudden-onset neuropsychiatric symptoms like OCD, differing from the classical presentation of tic disorders.
Referanslar
Bloch MH and Leckman JF. Tic and Motor Disorders: In Martin A, Bloch MH, Voklmar FR editor (editor). Lewis’s Child and Adolescent Psychiatry. Baltimore: 2018 Wolters Kluwer.
Amerikan Psikiyatri Birliği. Ruhsal Bozuklukların Tanısal ve Sayımsal El Kitabı, Beşinci Baskı Yeniden Gözden Geçirilmiş Tam Metin (DSM-V-TR). Köroğlu E (Çeviri ed.). Hekimler Yayın Birliği, Ankara, 2013.
Boudjouk PJ, Woods DW, Miltenberger RG, Long ES. Negative peer evaluation in adolescents: effects of tic disorders and trichotillomania. Child Fam Behav Ther. 2000; 22:17-28.
Eddy CM, Cavanna AE, Gulisano M, Agodi A, Barchitta M, Calì P, Robertson MM, Rizzo R. Clinical correlates of quality of life in Tourette syndrome. Mov Disord. 2011;26:735-738.
American Psychiatric Association. Diagnostic And Statistical Manual Of Mental Disorder. Third edition. Washington DC: APA, 1980
Amerikan Psikiyatri Birliği. Ruhsal Bozuklukların Tanısal ve Sayımsal El Kitabı, Dördüncü Baskı Yeniden Gözden Geçirilmiş Tam Metin (DSM-IV-TR). Köroğlu E (Çeviri ed.). Hekimler Yayın Birliği, Ankara, 2007, 151-160
Rickards H, Woolf I, Cavanna AE. “Trousseau’s disease:” A description of the Gilles de la Tourette syndrome 12 years before 1885. Mov Disord. 2010;25(14):2285-9.
Goetz CG, Chmura TA, Lanska DJ. History of tic disorders and Gilles de la Tourette syndrome: part 5 of the MDS-sponsored history of movement disorders exhibit, Barcelona, June 2000. Mov Disord. 2001;16(2):346-349.
Lajonchere C, Nortz M, Finger S. Gilles de la Tourette and the discovery of Tourette syndrome. Includes a translation of his 1884 article. Arch Neurol. 1996;53(6):567-574.
Chang SW, Piacentini J, Walkup JT. Behavioral treatment of Tourette syndrome: Past, present, and future. Clin Psychol; Sci Pract. 2007;14(3):268-73.
Snider LA, Seligman LD, Ketchen BR, et al.: Tics and problem behaviors in schoolchildren: prevalence, characterization, and associations. Pediatrics. 2002;110:331–6.
Khalifa N, von Knorring AL. Prevalence of tic disorders and Tourette syndrome in a Swedish school population. Dev Med Child Neurol. 2003;45(5):315-9.
Gadow KD, Nolan EE, Sprafkin J, Schwartz J. Tics and psychiatric comorbidity in children and adolescents. Dev Med Child Neurol. 2002;44(5):330-8.
Knight T, Steeves T, Day L, Lowerison M, Jette N, Pringsheim T. Prevalence of tic disorders: a systematic review and meta-analysis. Pediatr Neurol. 2012;47(2):77-90.
Towbin KE. Tic Disorders. Dulcan MK Editor, Dulcan’s Textbook of Child and Adolescent Psychiatry. Second edition. 2016. American Psychiatric Association publishing
Leckman JF, King RA, Bloch MH. Clinical Features of Tourette Syndrome and Tic Disorders. J Obsessive Compuls Relat Disord. 2014;3(4):372-379.
Peterson BS, Leckman JF. The temporal dynamics of tics in Gilles de la Tourette syndrome. Biol Psychiatry. 1998;44(12):1337-1348.
Modafferi S, Stornelli M, Chiarotti F, Cardona F, Bruni O. Sleep, anxiety and psychiatric symptoms in children with Tourette syndrome and tic disorders. Eur J Paediatr Neurol. 2016;20(5):696-703.
Conelea CA, Woods DW. The influence of contextual factors on tic expression in Tourette's syndrome: a review. J Psychosom Res. 2008;65(5):487-496.
Metzger H, Wanderer S, Roessner V. Tic disorders. IACAPAP e-Textbook of Child and Adolescent Mental Health Geneva: International Association for Child and Adolescent Psychiatry and Allied Professions. 2012.
Murphy TK, Lewin AB, Storch EA, Stock S; American Academy of Child and Adolescent Psychiatry (AACAP) Committee on Quality Issues (CQI). Practice parameter for the assessment and treatment of children and adolescents with tic disorders. J Am Acad Child Adolesc Psychiatry. 2013;52(12):1341-1359.
Leckman JF, Walker DE, Cohen DJ. Premonitory urges in Tourette's syndrome. Am J Psychiatry. 1993;150(1):98-102.
Park EG, Kim YH. Clinical features and neuropsychiatric comorbidities in pediatric patients with tic disorders: a retrospective chart review study from South Korea. BMC Psychiatry. 2021;21(1):14.
Nestadt G, Addington A, Samuels J, et al. The identification of OCD-related subgroups based on comorbidity. Biol Psychiatry. 2003;53(10):914-920.
Leckman JF, Zhang H, Alsobrook JP, Pauls DL. Symptom dimensions in obsessive-compulsive disorder: toward quantitative phenotypes. Am J Med Genet. 2001;105(1):28-30
Reese HE, Scahill L, Peterson AL, et al. The premonitory urge to tic: measurement, characteristics, and correlates in older adolescents and adults. Behav Ther. 2014;45(2):177-186.
State MW. The genetics of Tourette disorder. Curr Opin Genet Dev. 2011;21(3):302-309.
Felling RJ, Singer HS. Neurobiology of tourette syndrome: current status and need for further investigation. J Neurosci. 2011;31(35):12387-12395.
Karagiannidis I, Rizzo R, Tarnok Z, et al. Replication of association between a SLITRK1 haplotype and Tourette Syndrome in a large sample of families. Mol Psychiatry. 2012;17(7):665-668.
Karagiannidis I, Dehning S, Sandor P, et al. Support of the histaminergic hypothesis in Tourette syndrome: association of the histamine decarboxylase gene in a large sample of families. J Med Genet. 2013;50(11):760-764.
Dietrich A, Fernandez TV, King RA, et al. The Tourette International Collaborative Genetics (TIC Genetics) study, finding the genes causing Tourette syndrome: objectives and methods. Eur Child Adolesc Psychiatry. 2015;24(2):141-151.
Nambu A. Functional circuitry of the basal ganglia. In: Itakura T (ed) DBS for neurological disorders. Springer, New York, 2015: 1–11.
Leckman JF, Bloch MH, Smith ME, Larabi D, Hampson M. Neurobiological substrates of Tourette's disorder. J Child Adolesc Psychopharmacol. 2010;20(4):237-247.
McNaught KS, Mink JW. Advances in understanding and treatment of Tourette syndrome. Nat Rev Neurol. 2011;7(12):667-676.
Rothenberger A, Roessner V. Functional neuroimaging investigations of motor networks in Tourette syndrome. Behav Neurol. 2013;27(1):47-55.
Albin RL, Koeppe RA, Bohnen NI, et al. Increased ventral striatal monoaminergic innervation in Tourette syndrome. Neurology. 2003;61(3):310-315.
Wehmeyer L, Schüller T, Kiess J, et al. Target-Specific Effects of Deep Brain Stimulation for Tourette Syndrome: A Systematic Review and Meta-Analysis. Front Neurol. 2021;12:769275.
Butler T, Stern E, Silbersweig D. Functional neuroimaging of Tourette syndrome: advances and future directions. Adv Neurol. 2006;99:115-129.
Leckman JF, Vaccarino FM, Kalanithi PS, Rothenberger A (2006) Annotation: tourette syndrome: a relentless drumbeat—driven by misguided brain oscillations. J Child Psychol Psychiatry. 47:537–550.
Singer HS. Tourette Syndrome. Editor: Martino D. Leckman JF. Oxford Univ. Press. 2013: 276–300.
Baldan LC, Williams KA, Gallezot JD, et al. Histidine decarboxylase deficiency causes tourette syndrome: parallel findings in humans and mice [published correction appears in Neuron. 2014 Jun 4;82(5):1186-7]. Neuron. 2014;81(1):77-90.
Wong DF, Brasić JR, Singer HS, et al. Mechanisms of dopaminergic and serotonergic neurotransmission in Tourette syndrome: clues from an in vivo neurochemistry study with PET. Neuropsychopharmacology. 2008;33(6):1239-1251.
Mahone EM, Puts NA, Edden RAE, Ryan M, Singer HS. GABA and glutamate in children with Tourette syndrome: A 1H MR spectroscopy study at 7T. Psychiatry Res Neuroimaging. 2018;273:46-53.
Leckman JF. Tourette’s syndrome. Lancet. 2002;360:1577-1596).
Martino D, Zis P, Buttiglione M. The role of immune mechanisms in Tourette syndrome. Brain Res. 2015;1617:126-143.
Leckman JF, King RA, Gilbert DL, et al. Streptococcal upper respiratory tract infections and exacerbations of tic and obsessive-compulsive symptoms: a prospective longitudinal study. J Am Acad Child Adolesc Psychiatry. 2011;50(2):108-118.
Lin H, Williams KA, Katsovich L, et al. Streptococcal upper respiratory tract infections and psychosocial stress predict future tic and obsessive-compulsive symptom severity in children and adolescents with Tourette syndrome and obsessive-compulsive disorder. Biol Psychiatry. 2010;67(7):684-691.
Nicolson GL, Haier J. Role of chronic bacterial and viral infections in neurodegenerative, neurobehavioural, psychiatric, autoimmune and fatiguing illnesses: Part 1. Br J Med Pract. 2009;2:20–28.
Robertson MM. The prevalence and epidemiology of Gilles de la Tourette syndrome. Part 1: the epidemiological and prevalence studies. J Psychosom Res. 2008;65(5):461-472.
Centers for Disease Control & Prevention (CDC). Prevalence of diagnosed Tourette. 2009.
Jankovic J, Gelineau-Kattner R, Davidson A. Tourette's syndrome in adults. Mov Disord. 2010;25(13):2171-2175.
Robertson MM. Attention deficit hyperactivity disorder, tics and Tourette's syndrome: the relationship and treatment implications. A commentary. Eur Child Adolesc Psychiatry. 2006;15(1):1-11.
Kurlan R, Como PG, Miller B, et al. The behavioral spectrum of tic disorders: a community-based study. Neurology. 2002;59(3):414-420.
Coffey BJ, Biederman J, Smoller JW, et al. Anxiety disorders and tic severity in juveniles with Tourette's disorder. J Am Acad Child Adolesc Psychiatry. 2000;39(5):562-568.
Robertson MM, Williamson F, Eapen V. Depressive symptomatology in young people with Gilles de la Tourette Syndrome-- a comparison of self-report scales. J Affect Disord. 2006;91(2-3):265-268.
Deeb W, Malaty IA, Mathews CA. Tourette disorder and other tic disorders. Handb Clin Neurol. 2019;165:123-153.
Lewin AB, Chang S, McCracken J, McQueen M, Piacentini J. Comparison of clinical features among youth with tic disorders, obsessive-compulsive disorder (OCD), and both conditions. Psychiatry Res. 2010;178(2):317-322.
Budman CL, Bruun RD, Park KS, Lesser M, Olson M. Explosive outbursts in children with Tourette's disorder. J Am Acad Child Adolesc Psychiatry. 2000;39(10):1270-1276.
Leckman JF, Riddle MA, Hardin MT, et al. The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry. 1989;28(4):566-573.
Zaimoğlu S, Rodopman Arman A, Sabuncuoğlu O. Yale Genel Tik Ağırlığını Derecelendirme Ölçeği’nin güvenirlik çalışması. 5. Ulusal Çocuk ve Ergen Psikiyatrisi Kongresi, Ankara-Türkiye, 1995.
Martino D, Pringsheim TM, Cavanna AE, et al. Systematic review of severity scales and screening instruments for tics: Critique and recommendations. Mov Disord. 2017;32(3):467-473.
Yucelen AG, Rodopman-Arman A, Topcuoglu V, Yazgan MY, Fisek G. Interrater reliability and clinical efficacy of Children's Yale-Brown Obsessive-Compulsive Scale in an outpatient setting. Compr Psychiatry. 2006;47(1):48-53.
Robertson MM, Cavanna AE. The Gilles de la Tourette syndrome: a principal component factor analytic study of a large pedigree. Psychiatr Genet. 2007;17(3):143-152.
Vermilion J, Augustine E, Adams HR, et al. Tic Disorders are Associated With Lower Child and Parent Quality of Life and Worse Family Functioning. Pediatr Neurol. 2020;105:48-54.
Müller-Vahl KR, Szejko N, Verdellen C, et al. European clinical guidelines for Tourette syndrome and other tic disorders: summary statemen. Eur Child Adolesc Psychiatry. 2021;10.1007/s00787-021-01832-4.
Pringsheim T, Okun MS, Müller-Vahl K, et al. Practice guideline recommendations summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology. 2019;92(19):896-906.
Yu L, Li Y, Zhang J, et al. The therapeutic effect of habit reversal training for Tourette syndrome: a meta-analysis of randomized control trials. Expert Rev Neurother. 2020;20(11):1189-1196.
Steeves T, McKinlay BD, Gorman D, et al. Canadian guidelines for the evidence-based treatment of tic disorders: behavioural therapy, deep brain stimulation, and transcranial magnetic stimulation. Can J Psychiatry. 2012;57(3):144-151.
Shprecher D, Kurlan R. The management of tics. Mov Disord. 2009;24(1):15-24.
Pringsheim T, Doja A, Gorman D, et al. Canadian guidelines for the evidence-based treatment of tic disorders: pharmacotherapy. Can J Psychiatry. 2012;57(3):133-143. doi:10.1177/070674371205700302
Kurlan RM. Treatment of Tourette syndrome. Neurotherapeutics. 2014;11(1):161-165.
Robertson MM, Eapen V, Singer HS, et al. Gilles de la Tourette syndrome. Nat Rev Dis Primers. 2017;3:16097.
Mink JW, Walkup J, Frey KA, et al. Patient selection and assessment recommendations for deep brain stimulation in Tourette syndrome. Movement disorders: official journal of the Movement Disorder Society. 2006;21(11):1831-8.
Bloch MH, Landeros-Weisenberger A, Kelmendi B, Coric V, Bracken MB, Leckman JF. A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder. Mol Psychiatry. 2006;11(7):622-632.
Goodman WK, Storch EA, Geffken GR, Murphy TK. Obsessive-compulsive disorder in Tourette syndrome. J Child Neurol. 2006;21(8):704-714.
Skapinakis P, Papatheodorou T, Mavreas V. Antipsychotic augmentation of serotonergic antidepressants in treatment-resistant obsessive-compulsive disorder: a meta-analysis of the randomized controlled trials. Eur Neuropsychopharmacol. 2007;17(2):79-93.
Castellanos FX, Giedd JN, Elia J, et al. Controlled stimulant treatment of ADHD and comorbid Tourette's syndrome: effects of stimulant and dose. J Am Acad Child Adolesc Psychiatry. 1997;36(5):589-596.
Bloch MH, Panza KE, Landeros-Weisenberger A, Leckman JF. Meta-analysis: treatment of attention-deficit/hyperactivity disorder in children with comorbid tic disorders. J Am Acad Child Adolesc Psychiatry. 2009;48(9):884-893.
Roessner V, Eichele H, Stern JS, et al. European clinical guidelines for Tourette syndrome and other tic disorders-version 2.0. Part III: pharmacological treatment. Eur Child Adolesc Psychiatry. 2021.(Ahead of print)
Scahill L, Chappell PB, Kim YS, et al. A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. Am J Psychiatry. 2001;158(7):1067-1074.
Osland ST, Steeves TD, Pringsheim T. Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders. Cochrane Database Syst Rev. 2018;6(6):CD007990.
Swedo SE, Leonard HL, Garvey M, et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: Clinical description of the first 50 cases. Am J Psychiatry 1998;155(2):264–71.
Swedo SE. Sydenham’s chorea. A model for childhood autoimmune neuropsychiatric disorders. JAMA 1994;272(22):1788–
Swedo SE, Leckman JF, Rose NR. From research subgroup to clinical syndrome: modifying the PANDAS criteria to describe PANS (pediatric acute-onset neuropsychiatric syndrome). Pediatr Therapeut 2012;2:113.
Wilbur C, Bitnun A, Kronenberg S, Laxer RM, Levy DM, Logan WJ, Shouldice M, Yeh EA. PANDAS/PANS in childhood: Controversies and evidence. Paediatr Child Health. 2019 May;24(2):85-91.
Mell LK, Davis RL, Owens D. Association between streptococcal infection and obsessive-compulsive disorder, Tourette’s syndrome, and tic disorder. Pediatrics 2005;116(1):56–60.
Leckman JF, King RA, Gilbert DL, et al. Streptococcal upper respiratory tract infections and exacerbations of tic and obsessive-compulsive symptoms: A prospective longitudinal study. J Am Acad Child Adolesc Psychiatry 2011;50(2):108–18 e3.
Luo F, Leckman JF, Katsovich L, et al. Prospective longitudinal study of children with tic disorders and/or obsessive-compulsive disorder: Relationship of symptom exacerbations to newly acquired streptococcal infections. Pediatrics 2004;113(6):e578–85.
Gray SM, Bloch MH. Systematic review of proinflammatory cytokines in obsessive-compulsive disorder. Curr Psychiatry Rep 2012;14(3):220–8.
Parker-Athill EC, Ehrhart J, Tan J, Murphy TK. Cytokine correlations in youth with tic disorders. J Child Adolesc Psychopharmacol 2015;25(1):86–92.
Pranzatelli MR, Tate ED, Allison TJ. Case-control, exploratory study of cerebrospinal fluid chemokines/cytokines and lymphocyte subsets in childhood Tourette syndrome with positive streptococcal markers. Cytokine 2017;96:49–53.
Church AJ, Cardoso F, Dale RC, Lees AJ, Thompson EJ, Giovannoni G. Antibasal ganglia antibodies in acute and persistent Sydenham’s chorea. Neurology 2002;59(2):227–31. 18.
Pavone P, Bianchini R, Parano E, et al. Anti-brain antibodies in PANDAS versus uncomplicated streptococcal infection. Pediatr Neurol 2004;30(2):107–10.
Kirvan CA, Swedo SE, Snider LA, Cunningham MW. Antibody-mediated neuronal cell signaling in behavior and movement disorders. J Neuroimmunol 2006;179(1–2):173–9.
Singer HS, Hong JJ, Yoon DY, Williams PN. Serum autoantibodies do not differentiate PANDAS and Tourette syndrome from controls. Neurology 2005;65(11):1701–7.
Brilot F, Merheb V, Ding A, Murphy T, Dale RC. Antibody binding to neuronal surface in Sydenham chorea, but not in PANDAS or Tourette syndrome. Neurology 2011;76(17):1508–13.
Morris-Berry CM, Pollard M, Gao S, Thompson C, Singer HS; Tourette Syndrome Study Group. Anti-streptococcal, tubulin, and dopamine receptor 2 antibodies in children with PANDAS and Tourette syndrome: Single-point and longitudinal assessments. J Neuroimmunol 2013;264(1–2):106–13.
Hesselmark E, Bejerot S. Biomarkers for diagnosis of pediatric acute neuropsychiatric syndrome (PANS) - sensitivity and specificity of the Cunningham panel. J Neuroimmunol 2017;312:31–7.
Sigra S, Hesselmark E, Bejerot S. Treatment of PANDAS and PANS: a systematic review. Neurosci Biobehav Rev. 2018 Mar;86:51-65.
Zibordi F, Zorzi G, Carecchio M, Nardocci N. CANS: Childhood acute neuropsychiatric syndromes. Eur J Paediatr Neurol. 2018 Mar;22(2):316-320.
Chang K, Frankovich J, Cooperstock M, Cunningham M, Latimer ME, Murphy TK, Pasternack M, Thienemann M, Williams K, Walter J, et al. 2015. Clinical Evaluation of Youth with Pediatric Acute Onset Neuropsychiatric Syndrome (PANS): recommendations from the 2013 PANS Consensus Conference. J Child Adolesc Psychopharmacol. 25:3–13.
Lougee L, Perlmutter SJ, Nicolson R, Garvey MA, Swedo SE. 2000. Psychiatric disorders in first-degree relatives of children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS). J Am Acad Child Adolesc Psychiatry. 39:1120–1126.
Murphy TK, Storch EA, Turner A, Reid JM, Tan J, Lewin AB. 2010. Maternal history of autoimmune disease in children presenting with tics and/or obsessive–compulsive disorder. J Neuroimmunol. 229:243–247.
Chiarello F, Spitoni S, Hollander E, Matucci Cerinic M, Pallanti S. An expert opinion on PANDAS/PANS: highlights and controversies. Int J Psychiatry Clin Pract. 2017 Jun;21(2):91-98.
Waites KB, Balish MF, Atkinson TP. 2009. New insights into the pathogenesis and detection of Mycoplasma pneumoniae infections. Future Microbiol. 3:635–648
Murphy ML, Pichichero M. 2002. Prospective identification and treatment of children with pediatric autoimmune neuropsychiatric disorder associated with group A streptococcal infection (PANDAS). Arch Pediatr Adolesc Med. 156:356–361.
Snider LA, Lougee L, Slattery M, Grant P, Swedo SE. 2005. Antibiotic prophylaxis with azithromycin or penicillin for childhood-onset neuropsychiatric disorders. Biol Psychiatry. 57:788–792.
Ercan TE, Ercan G, Severge B, Arpaozu M, Karasu G. 2008. Mycoplasma pneumoniae infection and obsessive–compulsive disease: a case report. J Child Neurol. 23:338–340.
Rothstein JD, Patel S, Regan MR, Haenggeli C, Huang YH, Bergles DE, Jin L, Dykes Hoberg M, Vidensky S, Chung DS, et al. 2005. Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature. 433:73–77.
Sayyah M, Boostani H, Pakseresht S, Malayeri A. 2011. A preliminary randomized double-blind clinical trial on the efficacy of celecoxib as an adjunct in the treatment of obsessive–compulsive disorder. Psychiatry Res 189:403–406.
Garvey MA, Snider LA, Leitman SF, Werden R, Swedo SE. 2005. Treatment of Sydenham's chorea with intravenous immunoglobulin, plasma exchange, or prednisone. J Child Neurol. 20:424–429.
Demesh D, Virbalas JM, Bent JP. 2015. The role of tonsillectomy in the treatment of Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections (PANDAS). JAMA Otolaryngol Head Neck Surg. 141:272–275.
